RecallRadar

FDA Device recall Z-0368-2016

PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant u…

On 2015-12-09 the FDA classified a Class II recall of PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant u… by Merz North America, citing the expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0368-2016
ClassificationClass II
Statusterminated
Initiated2015-10-26
Published2015-12-09
Last updated2026-09-13 11:53 UTC
CompanyMerz North America
DistributionUS

Product

PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant used to treat vocal fold insufficiency.

Reason

The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.

Identifiers

code_info
Lot Number 100076901, 100077013, 100077249, 100077250, 100078691, 100079054, 100079213, 100079597, 100079954, 10008008…Lot Number 100076901, 100077013, 100077249, 100077250, 100078691, 100079054, 100079213, 100079597, 100079954, 100080082, 100081008, 100081401, 100081573, 100081916, 100082248, 100082468, 100082695, 100082729, 100083126, 100083785, 100083934

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0368-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.